Release Date: 17/03/10 09:52 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 10.57MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%